Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia.

Vargas-Alarcon G, Alvarez-Leon E, Fragoso JM, Vargas A, Martinez A, Vallejo M, Martinez-Lavin M.

BMC Musculoskelet Disord. 2012 Feb 20;13:23. doi: 10.1186/1471-2474-13-23.

2.

Dorsal root ganglia, sodium channels, and fibromyalgia sympathetic pain.

Martinez-Lavin M, Solano C.

Med Hypotheses. 2009 Jan;72(1):64-6. doi: 10.1016/j.mehy.2008.07.055. Epub 2008 Oct 8.

PMID:
18845401
3.

Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains.

Vargas-Alarcón G, Fragoso JM, Cruz-Robles D, Vargas A, Martinez A, Lao-Villadóniga JI, García-Fructuoso F, Vallejo M, Martínez-Lavín M.

Arthritis Rheum. 2009 Jul;60(7):2169-73. doi: 10.1002/art.24655.

4.

Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy.

Han C, Hoeijmakers JG, Liu S, Gerrits MM, te Morsche RH, Lauria G, Dib-Hajj SD, Drenth JP, Faber CG, Merkies IS, Waxman SG.

Brain. 2012 Sep;135(Pt 9):2613-28. doi: 10.1093/brain/aws187. Epub 2012 Jul 22.

PMID:
22826602
5.

Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7.

Estacion M, Han C, Choi JS, Hoeijmakers JG, Lauria G, Drenth JP, Gerrits MM, Dib-Hajj SD, Faber CG, Merkies IS, Waxman SG.

Mol Pain. 2011 Dec 2;7:92. doi: 10.1186/1744-8069-7-92.

6.

Pain perception is altered by a nucleotide polymorphism in SCN9A.

Reimann F, Cox JJ, Belfer I, Diatchenko L, Zaykin DV, McHale DP, Drenth JP, Dai F, Wheeler J, Sanders F, Wood L, Wu TX, Karppinen J, Nikolajsen L, Männikkö M, Max MB, Kiselycznyk C, Poddar M, Te Morsche RH, Smith S, Gibson D, Kelempisioti A, Maixner W, Gribble FM, Woods CG.

Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5148-53. doi: 10.1073/pnas.0913181107. Epub 2010 Mar 8.

7.

A sodium channel gene SCN9A polymorphism that increases nociceptor excitability.

Estacion M, Harty TP, Choi JS, Tyrrell L, Dib-Hajj SD, Waxman SG.

Ann Neurol. 2009 Dec;66(6):862-6. doi: 10.1002/ana.21895.

PMID:
20033988
8.

No mutations in the voltage-gated NaV1.7 sodium channel alpha1 subunit gene SCN9A in familial complex regional pain syndrome.

de Rooij AM, Gosso MF, Alsina-Sanchis E, Marinus J, van Hilten JJ, van den Maagdenberg AM.

Eur J Neurol. 2010 Jun 1;17(6):808-14. doi: 10.1111/j.1468-1331.2009.02931.x. Epub 2010 Jan 12.

PMID:
20074229
9.

Characterisation of Nav1.7 functional expression in rat dorsal root ganglia neurons by using an electrical field stimulation assay.

Fouillet A, Watson JF, Piekarz AD, Huang X, Li B, Priest B, Nisenbaum E, Sher E, Ursu D.

Mol Pain. 2017 Jan-Dec;13:1744806917745179. doi: 10.1177/1744806917745179. Epub 2017 Nov 22.

10.

Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable.

Dib-Hajj SD, Estacion M, Jarecki BW, Tyrrell L, Fischer TZ, Lawden M, Cummins TR, Waxman SG.

Mol Pain. 2008 Sep 19;4:37. doi: 10.1186/1744-8069-4-37.

11.

Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability.

Estacion M, Waxman SG, Dib-Hajj SD.

Mol Pain. 2010 Jun 8;6:35. doi: 10.1186/1744-8069-6-35.

12.

Painful neuropathies: the emerging role of sodium channelopathies.

Brouwer BA, Merkies IS, Gerrits MM, Waxman SG, Hoeijmakers JG, Faber CG.

J Peripher Nerv Syst. 2014 Jun;19(2):53-65. doi: 10.1111/jns5.12071. Review.

PMID:
25250524
13.

Nav1.7 is the predominant sodium channel in rodent olfactory sensory neurons.

Ahn HS, Black JA, Zhao P, Tyrrell L, Waxman SG, Dib-Hajj SD.

Mol Pain. 2011 May 10;7:32. doi: 10.1186/1744-8069-7-32.

14.

Regulation of Nav1.7: A Conserved SCN9A Natural Antisense Transcript Expressed in Dorsal Root Ganglia.

Koenig J, Werdehausen R, Linley JE, Habib AM, Vernon J, Lolignier S, Eijkelkamp N, Zhao J, Okorokov AL, Woods CG, Wood JN, Cox JJ.

PLoS One. 2015 Jun 2;10(6):e0128830. doi: 10.1371/journal.pone.0128830. eCollection 2015.

15.

Genetics and molecular pathophysiology of Na(v)1.7-related pain syndromes.

Dib-Hajj SD, Yang Y, Waxman SG.

Adv Genet. 2008;63:85-110. doi: 10.1016/S0065-2660(08)01004-3. Review.

PMID:
19185186
16.

SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain Severity.

Li QS, Cheng P, Favis R, Wickenden A, Romano G, Wang H.

Clin J Pain. 2015 Nov;31(11):976-82. doi: 10.1097/AJP.0000000000000205.

17.

Association between fibromyalgia syndrome and polymorphism of the IL-4 gene in a Turkish population.

Yigit S, Inanir A, Tekcan A, Inanir S, Tural S, Ates O.

Gene. 2013 Sep 15;527(1):62-4. doi: 10.1016/j.gene.2013.04.020. Epub 2013 May 2.

PMID:
23644020
18.

Familial pain syndromes from mutations of the NaV1.7 sodium channel.

Fischer TZ, Waxman SG.

Ann N Y Acad Sci. 2010 Jan;1184:196-207. doi: 10.1111/j.1749-6632.2009.05110.x. Review.

PMID:
20146699
19.

Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents.

Jarecki BW, Piekarz AD, Jackson JO 2nd, Cummins TR.

J Clin Invest. 2010 Jan;120(1):369-78. doi: 10.1172/JCI40801. Epub 2009 Dec 28.

20.

Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia.

Vargas-Alarcón G, Fragoso JM, Cruz-Robles D, Vargas A, Vargas A, Lao-Villadóniga JI, García-Fructuoso F, Ramos-Kuri M, Hernández F, Springall R, Bojalil R, Vallejo M, Martínez-Lavín M.

Arthritis Res Ther. 2007;9(5):R110.

Supplemental Content

Support Center